Regeneron Pharmaceuticals, Inc. (REGN) Regeneron Oncology Investor Event, ASCO 2020 Conference (Transcript)Seeking Alpha • 06/02/20
Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Regeneron Oncology Investor Event ASCO 2020 Conference (Transcript)Seeking Alpha • 06/02/20
Regeneron Pharmaceuticals, Inc. (REGN) CEO Len Schleifer Presents at Bernstein's 36th Annual Strategic Decisions Conference (Transcript)Seeking Alpha • 05/30/20
Libtayo® (cemiplimab-rwlc) Longer-term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ASCO 2020 Show Durable Responses that Deepen Over TimePRNewsWire • 05/29/20
Regeneron's Dupixent Data, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 05/28/20
Regeneron Announces Pricing of Secondary Offering of its Common Stock Held by SanofiPRNewsWire • 05/26/20
Sanofi to Sell Its 20.6% Stake in Regeneron, but Keep Their Collaboration IntactThe Motley Fool • 05/26/20
Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5 Billion Stock RepurchasePRNewsWire • 05/25/20
5 Biotech Stocks in Focus as Race for Coronavirus Vaccine Heats UpZacks Investment Research • 05/19/20